Yim T J, Tang S, Andino R
Department of Microbiology and Immunology, University of California, San Francisco, 94143-0414, USA.
Virology. 1996 Apr 1;218(1):61-70. doi: 10.1006/viro.1996.0166.
Expression of foreign antigens in the context of poliovirus vectors may provide a plausible approach to vaccine development. Poliovirus recombinants were constructed by fusing preS surface or core HBV proteins to the poliovirus polyprotein as previously described (Andino et al., Science, 265, 1448-1451, 1994). All recombinant viruses replicated with near wild-type efficiency in tissue culture cells and stably expressed high levels of the HBV antigens. The kinetics of recombinant RNA synthesis were indistinguishable from that of wild-type poliovirus. Exogenous proteins were not incorporated into the poliovirus particles, but HBV core proteins self-assembled into 100S particles composed of free HBV core proteins and fusions with poliovirus capsid proteins. Mice susceptible to poliovirus infection were inoculated with recombinant virus and elicited humoral immune responses against the HBV antigens.
在脊髓灰质炎病毒载体的背景下表达外源抗原可能为疫苗开发提供一种可行的方法。如先前所述(安迪诺等人,《科学》,第265卷,第1448 - 1451页,1994年),通过将前S表面或核心乙肝病毒蛋白与脊髓灰质炎病毒多聚蛋白融合构建脊髓灰质炎病毒重组体。所有重组病毒在组织培养细胞中以接近野生型的效率复制,并稳定表达高水平的乙肝病毒抗原。重组RNA合成的动力学与野生型脊髓灰质炎病毒的动力学没有区别。外源蛋白未被整合到脊髓灰质炎病毒颗粒中,但乙肝病毒核心蛋白自组装成由游离乙肝病毒核心蛋白以及与脊髓灰质炎病毒衣壳蛋白的融合物组成的100S颗粒。用重组病毒接种易感染脊髓灰质炎病毒的小鼠,可引发针对乙肝病毒抗原的体液免疫反应。